34 C
Delhi
Wednesday, September 30, 2020

US hands Pfizer, BioNTech $1.95b order for 100m Covid vaccines

- Advertisement -

US hands Pfizer, BioNTech $1.95b order for 100m Covid vaccinesNew York, July 22 (IANS) The US government has agreed to pay $1.95 billion for 100 million doses of a potential Covid-19 vaccine jointly developed by Pfizer and BioNTech, the two companies said on Wednesday.

The doses of the vaccine, BNT162, will be obtained after Pfizer successfully manufactures and obtains approval or emergency use authorisation from the US Food and Drug Administration (FDA).

The US government can also acquire up to an additional 500 million doses, said US-based Pfizer and Germany-based BioNTech.

“Depending on the success in clinical trials, today’s agreement will enable the delivery of approximately 100 million doses of this vaccine to the American people,” Alex Azar, Secretary, US Department of Health and Human Services, said in a statement.

Americans will receive the vaccine for free, consistent with the US government’s commitment for free access to Covid-19 vaccines.

“We made the early decision to begin clinical work and large-scale manufacturing at our own risk to ensure that the product would be available immediately if our clinical trials prove successful and an Emergency Use Authorisation is granted,” Albert Bourla, Pfizer Chairman and CEO, said in a statement.

“We are honored to be a part of this effort to provide Americans access to protection from this deadly virus,” the statement added.

The BNT162 programme is based on BioNTech’s proprietary mRNA technology and is supported by Pfizer’s global vaccine development and manufacturing capabilities.

The BNT162 vaccine candidates are undergoing clinical studies.

“We are also in advanced discussions with multiple other government bodies and we hope to announce additional supply agreements soon. Our goal remains to bring a safe and effective Covid-19 vaccine to many people around the world, as quickly as we can,” said Ugur Sahin, CEO and Co-founder of BioNTech.

The Pfizer/BioNTech vaccine development programme is evaluating at least four experimental vaccines, each of which represents a unique combination of messenger RNA (mRNA) format and target antigen.

On July 1, Pfizer and BioNTech announced preliminary data from BNT162b1, the most advanced of the four mRNA formulations.

The early data demonstrates that BNT162b1 is able to produce neutralising antibodies in humans at or above the levels observed in the plasma from patients who have recovered from Covid-19, and this was shown at relatively low dose levels.

Local reactions and systemic events were dose-dependent, generally mild to moderate, and transient. No serious adverse events were reported.

On July 20, the companies announced early positive update from German Phase 1/2 Covid-19 vaccine study, including first T Cell response data.

Recently, two of the companies’ four investigational vaccine candidates (BNT162b1 and BNT162b2) received Fast Track designation from the US FDA.

This designation was granted based on preliminary data from Phase 1/2 studies that are currently ongoing in the US and Germany as well as animal immunogenicity studies.

Further data from the ongoing Phase 1/2 clinical trials of the four vaccine candidates will enable the selection of a lead candidate and dose level for an anticipated large, global Phase 2b/3 safety and efficacy study that may begin as early as later this month, pending regulatory approval.

If the ongoing studies are successful, Pfizer and BioNTech said they expect to be ready to seek Emergency Use Authorisation or some form of regulatory approval as early as October 2020.

The companies currently expect to manufacture globally up to 100 million doses by the end of 2020 and potentially more than 1.3 billion doses by the end of 2021, subject to final dose selection from their clinical trial.

–IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

Trump, Biden trade early jabs in first presidential debate

New York, Sep 30 (IANS) With exactly 35 days until the 2020 US election, President Donald Trump and Democratic challenger Joe Biden waded into...

Serum Institute to manufacture 200mn doses of Covid-19 vaccine

New Delhi, Sep 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi...

87million were likely exposed to Covid-19, 1 in 15 had antibodies

New Delhi, Sep 29 (IANS) The key findings of the second round of sero-survey conducted by the Indian Council of Medical Research (ICMR) suggested...

New global test will give Covid test results ‘in minutes’

Geneva, Sep 29 (IANS) A test that can diagnose Covid-19 in minutes will dramatically expand the capacity to detect cases in low- and middle-income...

Health ministry launches web portal for COVID-19 vaccine updates

New Delhi, Sep 28 (PTI) The Union Health Ministry on Monday launched a web portal that will provide all important information on COVID-19, vaccine...

Dependence of global supply chain on single source exposed: PM Modi

New Delhi, Sep 28 (PTI) The coronavirus pandemic has shown the risk involved in excessive dependence of the global supply chain on any single...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Serum Institute to manufacture 200mn doses of Covid-19 vaccine

New Delhi, Sep 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi...

Serum Institute to manufacture 200mn doses of Covid-19 vaccine

New Delhi, Sep 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi...

87million were likely exposed to Covid-19, 1 in 15 had antibodies

New Delhi, Sep 29 (IANS) The key findings of the second round of sero-survey conducted by the Indian Council of Medical Research (ICMR) suggested...

Health ministry launches web portal for COVID-19 vaccine updates

New Delhi, Sep 28 (PTI) The Union Health Ministry on Monday launched a web portal that will provide all important information on COVID-19, vaccine...

Dependence of global supply chain on single source exposed: PM Modi

New Delhi, Sep 28 (PTI) The coronavirus pandemic has shown the risk involved in excessive dependence of the global supply chain on any single...

Over 3,000 vaccinated against coronavirus in Moscow

Moscow, Sep 28 (IANS) More than 3,000 people in Moscow have been vaccinated against the novel coronavirus, the media has reported."More than 3,000 volunteers...

Trending News In India

All-round effort helps SunRisers notch first win

Abu Dhabi, Sep 30 (IANS/GloFans) SunRisers Hyderabad (SRH) finally opened their account -- the last of the eight teams to do so -- with clinical...

All Babri demolition accused acquitted as act was ‘spontaneous’

Lucknow, Sep 30 (IANS) A Special CBI court hearing the Babri mosque demolition case of December 6, 1992, acquitted all the 32 accused on...

Hathras gang-rape case:PM calls for strict action, Adityanath set ups SIT

Lucknow Sep 30 (PTI) Amid outrage over the Hathras gang-rape case, Prime Minister Narendra Modi spoke with UP Chief Minister Yogi Adityanath and sought...

Hathras victim cremated, police denies coercion

Hathras, Sep 30 (iANS) A 19-year-old Dalit woman from Hathras, who died in a Delhi hospital after sustaining grievous injuries during an alleged gang...

‘Indian chemical industry can contribute $300 bn to GDP by 2025’

New Delhi, Sep 29 (IANS) The Indian chemical industry has a huge role to play to make India a $5 trillion economy, with a potential...

SEBI amends norms for delisting of subsidiaries, debenture trustees

Mumbai, Sep 29 (IANS) The Securities and Exchange Board of India (SEBI) on Tuesday decided to amend regulations for delisting of equity shares, stipulating...

Trending Showbiz

AIIMS, CBI looking at legal aspects before reaching logical conclusion in SSR case

New Delhi, Sep 29 (IANS) The Forensic Department of the All India Institute of Medical Sciences (AIIMS), which has been roped in by the...

We are conducting probe into Sushant case professionally, says CBI

New Delhi, Sep 28 (IANS) Days after Vikas Singh, lawyer of Sushant Singh Rajput’s family, sought updates in the Central Bureau of Investigation (CBI) investigation, the...

NCB seizes phones of Deepika, Rakul, Simone, Karishma in drugs case

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB), which quizzed Bollywood actors Rakul Preet Singh, Deepika Padukone, her former manager Karishma Prakash, and...

NCB quizzes Deepika, Sara, Shraddha in drug case related to SSR death

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB) on Saturday questioned Bollywood divas Deepika Padukone, Sara Ali Khan, Shraddha Kapoor for several hours...

‘CBI delay in converting abetment to suicide to murder frustrating’

Mumbai, Sep 25 (IANS) Vikas Singh, family lawyer of late actor Sushant Singh Rajput, on Friday stated that the delay being by Central Bureau...

NCB questions Rakul, Deepika’s ex-manager, Dharma Productions honcho

Mumbai, Sep 25 (IANS) The Narcotics Control Bureau (NCB) on Friday is questioning Bollywood actor Rakul Preet Singh, Dharma Productions executive producer Kshitij Ravi...

Trending Sports

All-round effort helps SunRisers notch first win

Abu Dhabi, Sep 30 (IANS/GloFans) SunRisers Hyderabad (SRH) finally opened their account -- the last of the eight teams to do so -- with clinical...

Kohli wins Super Over thriller for RCB, Kishan’s 99 in vain

Dubai, Sep 29 (IANS/GloFans) In yet another roller-coaster contest, Royal Challengers Bangalore (RCB) edged out Mumbai Indians (MI) in a Super Over tie-breaker - the...

ICC gets recognition for two digital initiatives in Leaders in Sports Awards

Dubai, Sep 28 (PTI) The International Cricket Council (ICC) has been recognised for its twin digital initiatives at the prestigious Leaders in Sports Awards...

Played nearly 500 games, can speak to any player says Ganguly

Kolkata, Sep 28 (PTI) His nearly "500 international match experience" gives him the right to speak and guide any player "be it Shreyas Iyer...

Went through rigorous physical, mental transformation for 1996 Olympics, says Paes

New Delhi, Sep 28 (IANS) The year was 1996 and no Indian had won an individual medal at the Olympics 44 years prior to...

Sensational Tewatia hits five sixes in an over as RR defeats KXIP

Sharjah, Sep 28 (PTI) Rahul Tewatia struck five sixes in an over at the fag end of the match as Rajasthan Royals recorded the...

Latest Trending News In India

Supreme Court refuses to postpone civil service exam of 2020

New Delhi, Sep 30 (PTI) The Supreme Court Wednesday refused to postpone UPSC civil services preliminary exam, to be held on October 4, because...

All Babri demolition accused acquitted as act was ‘spontaneous’

Lucknow, Sep 30 (IANS) A Special CBI court hearing the Babri mosque demolition case of December 6, 1992, acquitted all the 32 accused on...

Hathras gang-rape case:PM calls for strict action, Adityanath set ups SIT

Lucknow Sep 30 (PTI) Amid outrage over the Hathras gang-rape case, Prime Minister Narendra Modi spoke with UP Chief Minister Yogi Adityanath and sought...

Hathras victim cremated, police denies coercion

Hathras, Sep 30 (iANS) A 19-year-old Dalit woman from Hathras, who died in a Delhi hospital after sustaining grievous injuries during an alleged gang...

‘Indian chemical industry can contribute $300 bn to GDP by 2025’

New Delhi, Sep 29 (IANS) The Indian chemical industry has a huge role to play to make India a $5 trillion economy, with a potential...